{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T06:17:42Z","timestamp":1791958662198,"version":"4.3.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s12350-020-02201-5","type":"journal-article","created":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T10:03:27Z","timestamp":1590573807000},"page":"86-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Quantitative Assessment of Cardiac Hypermetabolism and Perfusion for Diagnosis of Cardiac Sarcoidosis"],"prefix":"10.1016","volume":"29","author":[{"given":"Robert J.H.","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastien","family":"Cadet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payam","family":"Pournazari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"Pope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Kransdorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele A.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jignesh","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balaji","family":"Tamarappoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Berman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr J.","family":"Slomka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s12350-020-02201-5_bib1","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nrcardio.2015.22","article-title":"Pathophysiology and clinical management of cardiac sarcoidosis","volume":"12","author":"Hamzeh","year":"2015","journal-title":"Nature Rev Cardiol"},{"key":"10.1007\/s12350-020-02201-5_bib2","first-page":"50","article-title":"Cardiac sarcoidosis\u2014state of the art review","volume":"6","author":"Hulten","year":"2016","journal-title":"Cardiovasc Diagn Ther"},{"key":"10.1007\/s12350-020-02201-5_bib3","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.pcad.2009.11.010","article-title":"Diagnosis and management of cardiac sarcoidosis","volume":"52","author":"Dubrey","year":"2010","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1007\/s12350-020-02201-5_bib4","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1540-8167.2008.01417.x","article-title":"The work-up and management of patients with apparent or subclinical cardiac sarcoidosis: with emphasis on the associated heart rhythm abnormalities","volume":"20","author":"Soejima","year":"2009","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1007\/s12350-020-02201-5_bib5","first-page":"1034","article-title":"Corticosteroid therapy for cardiac sarcoidosis: a systematic review","volume":"29","author":"Sadek","year":"2013","journal-title":"Can J Cardiol"},{"key":"10.1007\/s12350-020-02201-5_bib6","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1152\/ajplegacy.1973.224.3.651","article-title":"Acute effect of prednisolone on renal handling of sodium","volume":"224","author":"Popovtzer","year":"1973","journal-title":"Am J Physiol"},{"key":"10.1007\/s12350-020-02201-5_bib7","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1148\/rg.2018180053","article-title":"PET\/CT in the diagnosis and workup of sarcoidosis: focus on atypical manifestations","volume":"38","author":"Akaike","year":"2018","journal-title":"RadioGraphics"},{"key":"10.1007\/s12350-020-02201-5_bib8","first-page":"1030","article-title":"Identification of cardiac sarcoidosis with (13)N-NH(3)\/(18)F-FDG PET","volume":"44","author":"Yamagishi","year":"2003","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-020-02201-5_bib9","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","article-title":"Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis","volume":"63","author":"Blankstein","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-020-02201-5_bib10","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s12149-014-0806-0","article-title":"Recommendations for (18)F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis","volume":"28","author":"Ishida","year":"2014","journal-title":"Ann Nucl Med"},{"key":"10.1007\/s12350-020-02201-5_bib11","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s12350-014-9901-9","article-title":"Quantitative interpretation of FDG PET\/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis","volume":"21","author":"Ahmadian","year":"2014","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02201-5_bib12","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12350-013-9828-6","article-title":"Reduction in (1)(8)F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis","volume":"21","author":"Osborne","year":"2014","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02201-5_bib13","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.hrthm.2012.02.010","article-title":"Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators","volume":"9","author":"Betensky","year":"2012","journal-title":"Heart rhythm."},{"key":"10.1007\/s12350-020-02201-5_bib14","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s12350-016-0522-3","article-title":"ASNC imaging guidelines\/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures","volume":"23","author":"Dilsizian","year":"2016","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02201-5_bib15","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2967\/jnumed.112.112219","article-title":"Multisoftware reproducibility study of stress and rest myocardial blood flow assessed with 3D dynamic PET\/CT and a 1-tissue-compartment model of 82Rb kinetics","volume":"54","author":"Dekemp","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-020-02201-5_bib16","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s12350-011-9496-3","article-title":"Automated quantitative Rb-82 3D PET\/CT myocardial perfusion imaging: normal limits and correlation with invasive coronary angiography","volume":"19","author":"Nakazato","year":"2012","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02201-5_bib17","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/ehjci\/jex146","article-title":"A joint procedural position statement on imaging in cardiac sarcoidosis","volume":"18","author":"Slart","year":"2017","journal-title":"EHJ Cardiovasc Imaging"},{"key":"10.1007\/s12350-020-02201-5_bib18","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"10.1007\/s12350-020-02201-5_bib19","doi-asserted-by":"crossref","unstructured":"Youden WJ. Index for rating diagnostic tests. Cancer 1950; 3: 32\u201335. 10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3"},{"key":"10.1007\/s12350-020-02201-5_bib20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s12149-018-1250-3","article-title":"Diagnostic value of quantitative assessment of cardiac (18)F-fluoro-2-deoxyglucose uptake in suspected cardiac sarcoidosis","volume":"32","author":"Lebasnier","year":"2018","journal-title":"Ann Nucl Med"},{"key":"10.1007\/s12350-020-02201-5_bib21","first-page":"512","article-title":"Quantitative interpretation of FDG PET for cardiac sarcoidosis reclassifies visually interpreted studies and potentially reduces unnecessary downstream interventions","volume":"58","author":"Varghese","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-020-02201-5_bib22","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.2967\/jnumed.116.187203","article-title":"Inter- and intraobserver agreement of (18)F-FDG PET\/CT image interpretation in patients referred for assessment of cardiac sarcoidosis","volume":"58","author":"Ohira","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-020-02201-5_bib23","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13550-016-0207-6","article-title":"A dual tracer (68)Ga-DOTANOC PET\/CT and (18)F-FDG PET\/CT pilot study for detection of cardiac sarcoidosis","volume":"6","author":"Gormsen","year":"2016","journal-title":"EJNMMI Res"},{"key":"10.1007\/s12350-020-02201-5_bib24","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s12350-016-0490-7","article-title":"The response of FDG uptake to immunosuppressive treatment on FDG PET\/CT imaging for cardiac sarcoidosis","volume":"24","author":"Ahmadian","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02201-5_bib25","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1161\/CIRCIMAGING.112.000289","article-title":"Is there an association between clinical presentation and the location and extent of myocardial involvement of cardiac sarcoidosis as assessed by 18F-fluorodoexyglucose positron emission tomography?","volume":"6","author":"Ardle","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1007\/s12350-020-02201-5_bib26","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart rhythm"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-020-02201-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12350-020-02201-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123001952?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123001952?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-020-02201-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:10:06Z","timestamp":1761027006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358123001952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1071358123001952"],"URL":"https:\/\/doi.org\/10.1007\/s12350-020-02201-5","relation":{},"ISSN":["1071-3581"],"issn-type":[{"value":"1071-3581","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantitative Assessment of Cardiac Hypermetabolism and Perfusion for Diagnosis of Cardiac Sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12350-020-02201-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 American Society of Nuclear Cardiology. Published by ELSEVIER INC. All rights reserved. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}